AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2025
Jun 17, 2025
32559_dirs_2025-06-16_8f94df7d-c8f7-4e6e-b3b0-feffc5d90bd1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2025-06-13
Reporting Person: Gengos Andrew (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-13 | Common Stock | P | 5000.00 | $3.75 | Acquired | 5000.00 | Direct |
| 2025-06-13 | Common Stock | P | 5000.00 | $3.72 | Acquired | 10000.00 | Direct |
| 2025-06-16 | Common Stock | P | 5000.00 | $3.9465 | Acquired | 15000.00 | Direct |